These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

629 related items for PubMed ID: 27653897

  • 1. Association between high biomarker probability of Alzheimer's disease and improvement of clinical outcomes after shunt surgery in patients with idiopathic normal pressure hydrocephalus.
    Kazui H, Kanemoto H, Yoshiyama K, Kishima H, Suzuki Y, Sato S, Suehiro T, Azuma S, Yoshimine T, Tanaka T.
    J Neurol Sci; 2016 Oct 15; 369():236-241. PubMed ID: 27653897
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Idiopathic normal-pressure hydrocephalus, cerebrospinal fluid biomarkers, and the cerebrospinal fluid tap test.
    Kang K, Ko PW, Jin M, Suk K, Lee HW.
    J Clin Neurosci; 2014 Aug 15; 21(8):1398-403. PubMed ID: 24836892
    [Abstract] [Full Text] [Related]

  • 4. Idiopathic normal pressure hydrocephalus has a different cerebrospinal fluid biomarker profile from Alzheimer's disease.
    Jingami N, Asada-Utsugi M, Uemura K, Noto R, Takahashi M, Ozaki A, Kihara T, Kageyama T, Takahashi R, Shimohama S, Kinoshita A.
    J Alzheimers Dis; 2015 Aug 15; 45(1):109-15. PubMed ID: 25428256
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Alzheimer's Disease Biomarkers in Idiopathic Normal Pressure Hydrocephalus: Linking Functional Connectivity and Clinical Outcome.
    Bommarito G, Van De Ville D, Frisoni GB, Garibotto V, Ribaldi F, Stampacchia S, Assal F, Allali G, Griffa A.
    J Alzheimers Dis; 2021 Aug 15; 83(4):1717-1728. PubMed ID: 34459399
    [Abstract] [Full Text] [Related]

  • 7. Frontal Behavior Syndromes in Idiopathic Normal Pressure Hydrocephalus as a Function of Alzheimer's Disease Biomarker Status.
    Niermeyer M, Gaudet C, Malloy P, Piryatinsky I, Salloway S, Klinge P, Lee A.
    J Int Neuropsychol Soc; 2020 Oct 15; 26(9):883-893. PubMed ID: 32430087
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The predictive value of T-tau and AB1-42 levels in idiopathic normal pressure hydrocephalus.
    Craven CL, Baudracco I, Zetterberg H, Lunn MPT, Chapman MD, Lakdawala N, Watkins LD, Toma AK.
    Acta Neurochir (Wien); 2017 Dec 15; 159(12):2293-2300. PubMed ID: 28889317
    [Abstract] [Full Text] [Related]

  • 11. Forget About Memory: Disentangling the Amnestic Syndrome in Idiopathic Normal Pressure Hydrocephalus.
    Lingenberg A, Herrmann FR, Armand S, Péron J, Assal F, Allali G.
    J Alzheimers Dis; 2024 Dec 15; 101(4):1205-1216. PubMed ID: 39302366
    [Abstract] [Full Text] [Related]

  • 12. Preoperative Phosphorylated Tau Concentration in the Cerebrospinal Fluid Can Predict Cognitive Function Three Years after Shunt Surgery in Patients with Idiopathic Normal Pressure Hydrocephalus.
    Nakajima M, Miyajima M, Ogino I, Akiba C, Kawamura K, Kamohara C, Fusegi K, Harada Y, Hara T, Sugano H, Tange Y, Karagiozov K, Kasuga K, Ikeuchi T, Tokuda T, Arai H.
    J Alzheimers Dis; 2018 Dec 15; 66(1):319-331. PubMed ID: 30248058
    [Abstract] [Full Text] [Related]

  • 13. Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus versus Alzheimer's Disease and Subcortical Ischemic Vascular Disease: A Systematic Review.
    Manniche C, Hejl AM, Hasselbalch SG, Simonsen AH.
    J Alzheimers Dis; 2019 Dec 15; 68(1):267-279. PubMed ID: 30741681
    [Abstract] [Full Text] [Related]

  • 14. Cerebrospinal Fluid Diagnostics of Alzheimer's Disease in Patients with Idiopathic Normal Pressure Hydrocephalus.
    Vanninen A, Lukkarinen H, Kokkola T, Koivisto AM, Kokki M, Musialowicz T, Hiltunen M, Zetterberg H, Leinonen V, Herukka SK, Rauramaa T.
    J Alzheimers Dis; 2023 Dec 15; 94(2):727-736. PubMed ID: 37334597
    [Abstract] [Full Text] [Related]

  • 15. Cerebrospinal fluid biomarkers for prognosis of long-term cognitive treatment outcomes in patients with idiopathic normal pressure hydrocephalus.
    Nakajima M, Miyajima M, Ogino I, Akiba C, Sugano H, Hara T, Fusegi K, Karagiozov K, Arai H.
    J Neurol Sci; 2015 Oct 15; 357(1-2):88-95. PubMed ID: 26169158
    [Abstract] [Full Text] [Related]

  • 16. Effect of lumbo-peritoneal shunt surgery on neuropsychiatric symptoms in patients with idiopathic normal pressure hydrocephalus.
    Kanemoto H, Kazui H, Suzuki Y, Sato S, Kishima H, Yoshimine T, Yoshiyama K.
    J Neurol Sci; 2016 Feb 15; 361():206-12. PubMed ID: 26810545
    [Abstract] [Full Text] [Related]

  • 17. Cerebrospinal fluid Aβ42, t-tau, and p-tau levels in the differential diagnosis of idiopathic normal-pressure hydrocephalus: a systematic review and meta-analysis.
    Chen Z, Liu C, Zhang J, Relkin N, Xing Y, Li Y.
    Fluids Barriers CNS; 2017 May 10; 14(1):13. PubMed ID: 28486988
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of coexistence of Alzheimer's disease in idiopathic normal pressure hydrocephalus using ELISA analyses for CSF biomarkers.
    Lim TS, Choi JY, Park SA, Youn YC, Lee HY, Kim BG, Joo IS, Huh K, Moon SY.
    BMC Neurol; 2014 Apr 01; 14():66. PubMed ID: 24690253
    [Abstract] [Full Text] [Related]

  • 19. Soluble amyloid precursor protein α in the cerebrospinal fluid as a diagnostic and prognostic biomarker for idiopathic normal pressure hydrocephalus.
    Miyajima M, Nakajima M, Ogino I, Miyata H, Motoi Y, Arai H.
    Eur J Neurol; 2013 Feb 01; 20(2):236-42. PubMed ID: 22672777
    [Abstract] [Full Text] [Related]

  • 20. Increased Cerebrospinal Fluid Levels of Soluble Triggering Receptor Expressed on Myeloid Cells 2 and Chitinase-3-Like Protein 1 in Idiopathic Normal-Pressure Hydrocephalus.
    Yang F, Yang L, Fang X, Deng Y, Mao R, Yan A, Wei W.
    J Alzheimers Dis; 2023 Feb 01; 93(4):1341-1354. PubMed ID: 37182875
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.